Genetic variation in the tumor necrosis factor-α promoter region and in the stress protein hsp70-2: Susceptibility and prognostic implications in breast carcinoma

Cancer

Volumn 91, Issue 4, 2001, Pages 672-678

  Mestiri, Souhir ^a   Bouaouina, Noureddine ^a,b   Ahmed, Slim Ben ^b   Khedhaier, Achraf ^a   Jrad, Besma Belhadj ^a   Remadi, Sami ^a,c   Chouchane, Lotfi ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FARHAT HACHED HOSPITAL   (Tunisia)

^c Laboratoire Cytopath   (Tunisia)

Author keywords

Breast carcinoma; Polymorphism; Prognosis; Stress proteins; Tumor necrosis factor

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; HEAT SHOCK PROTEIN 70; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL; TUNISIA;

ADULT; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; GENOTYPE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035864931     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010215)91:4<672::AID-CNCR1050>3.0.CO;2-J     Document Type: Article

References (37)

1. An endotoxin-induced serum factor that causes necrosis of tumors
2. The tumor necrosis factor ligand and receptor families
3. Nuclear factor Kappa B: A pivotal transcription factor in chronic inflammatory diseases
4. Elevated circulating levels of TNF-α and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients
5. The tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients
6. Cachectin/tumor necrosis factor induces cachexia, anemia and inflammation
7. TNF and Mae West or: Death from too much of a good thing
8. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55-and 75kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer
9. Tumor necrosis factor-α (TNF-α) in patients who have asbestosis and develop cancer
10. Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor
11. Endogenous tumor necrosis factor exert its protective function intracellulary against the cytotoxicity of exogenous tumor necrosis factor
12. Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity
13. Tumor necrosis factor as an endogenous tumor promotor
14. A new tumor promotion pathway and its inhibitors
15. Single base polymorphism in the human tumor necrosis factor alpha (TNFα) gene detectable by Nco1 restriction of PCR product
16. Effects of a tumor necrosis factor (TNF-α) promotor base transition on transcriptional activity
17. Human major histocompatibility complex contains genes for the major heat shock protein HSP70
18. Structure and expression of the MHC-linked HSP70 genes
19. Conserved features of eukaryotic HSP70 genes revealed by comparison with the nucleotide sequence of human HSP70
20. Cellular and subcellular distribution of PBP 72/74, a peptide-binding proteins that plays a role in antigen processing
21. A mechanism for the specific immunogenicity of heat shock protein-chaperoned-peptides
22. Molecular chaperones in the etiologiy and therapy of cancer
23. Polymorphism in the tumor necrosis factor-α promotor region and in the heat shock protein 70 genes associated with malignant tumors
24. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation
25. Polymorphism in tumor necrosis factor genes associated with muocutaneous leishmaniasis
26. Polymorphic analysis of the three MHC-linked HSP70 genes
27. Design and interpretation of studies of the major histocompatibility complex in disease
28. Principles and quantitative methods
29. Nonparametric estimation from incomplete observations
30. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
31. Some aspects of analysis of covariance
32. Endogenous tumor necrosis factor as a predictor of doxorubicin sensitivity in leukemic patients
33. Heat shock and apoptosis: The two defense systems of the organisms may have overlapping molecular elements
34. Overexpression of major heat shock protein HSP70 inhibits tumor necrosis factor-induced activation of phospholipase A2
35. Response to human breast cancer cells to heat shock and chemotherapeutic drugs
36. Heat-shock protein induction in adriamycin and picor-navirus-infected cardiocytes
37. Heat shock protein HSP70 in patients with axillary lymph node-negative breast cancer: Prognostic implications